Answers are grounded in this paper and cite their sources.
This review highlights regional variations and care gaps in pulmonary fibrosis, suggesting a need for improved drug development and awareness initiatives.
PF is an important global healthcare challenge, especially due to its clinical heterogeneity and geographic variation. Gaps in care need to be addressed by prioritising new drug development and ensuring wider dissemination of PF-related awareness and services.
No takes yet. Share an insight, caveat, or question.
Dhooria et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: